Julide Sisman1, Lina Chalak2, Roy Heyne2, Marcia Pritchard3, Devri Weakley3, L Steven Brown4, Charles R Rosenfeld2. 1. Department of Pediatrics, Division of Neonatal-Perinatal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. julide.sisman@utsouthwestern.edu. 2. Department of Pediatrics, Division of Neonatal-Perinatal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. 3. Department of Radiology, University of Texas Southwestern Medical Center and Children's Health System of Texas, Dallas, TX, USA. 4. Department of Health System Research, Parkland Health and Hospital System, Dallas, TX, USA.
Abstract
OBJECTIVE: To examine the inter-rater reliability for the diagnosis of LSV on cranial ultrasound (cUS), determine the risk factors associated with LSV and its progression, and examine neurodevelopmental outcome. STUDY DESIGN: Prospective case-control study of neonates ≤32wks of gestation assessed for LSV by serial cUS (n = 1351) between 2012 and 2014 and their neurodevelopment at 18-36mon-corrected age compared to controls. RESULTS: Agreement for LSV on cUS improved from Κappa 0.4-0.7 after establishing definitive criteria and guidelines. BPD was the only variable associated with the occurrence and the progression of LSV. Cytomegalovirus (CMV) infection occurred in one neonate (1.5%). Neurodevelopmental outcome of neonates with LSV did not differ from controls. CONCLUSIONS: Establishment of well-defined stages of LSV improves the reliability of the diagnosis and allows identification of neonates with progression of LSV. Although LSV was associated with BPD, it was not associated with congenital CMV infection.
OBJECTIVE: To examine the inter-rater reliability for the diagnosis of LSV on cranial ultrasound (cUS), determine the risk factors associated with LSV and its progression, and examine neurodevelopmental outcome. STUDY DESIGN: Prospective case-control study of neonates ≤32wks of gestation assessed for LSV by serial cUS (n = 1351) between 2012 and 2014 and their neurodevelopment at 18-36mon-corrected age compared to controls. RESULTS: Agreement for LSV on cUS improved from Κappa 0.4-0.7 after establishing definitive criteria and guidelines. BPD was the only variable associated with the occurrence and the progression of LSV. Cytomegalovirus (CMV) infection occurred in one neonate (1.5%). Neurodevelopmental outcome of neonates with LSV did not differ from controls. CONCLUSIONS: Establishment of well-defined stages of LSV improves the reliability of the diagnosis and allows identification of neonates with progression of LSV. Although LSV was associated with BPD, it was not associated with congenital CMV infection.
Authors: Anju Jacob; Shameer M Habeeb; Leal Herlitz; Eva Simkova; Jwan F Shekhy; Alan Taylor; Walid Abuhammour; Ahmad Abou Tayoun; Martin Bitzan Journal: Front Pediatr Date: 2020-11-27 Impact factor: 3.418
Authors: Jessica Patrick-Esteve; Christy Mumphrey; David Yu; Emily Masoumy; Jeremy Lawson; David Hebert; Brian Barkemeyer Journal: Front Pediatr Date: 2022-08-12 Impact factor: 3.569